• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛆虫清创疗法治疗 Behçet 病难治性下肢溃疡的疗效:一项开放标签研究。

Efficacy of maggot debridement therapy on refractory leg ulcers of Behçet disease: an open-label study.

机构信息

Department of Dermatology, University of Medical Sciences, Haydarpasa Numune Training and Research Hospital, Istanbul, Turkey.

Department of Microbiology, İstanbul University, Cerrahpasa Medical Faculty, İstanbul, Turkey.

出版信息

Clin Exp Dermatol. 2021 Jul;46(5):834-841. doi: 10.1111/ced.14539. Epub 2021 May 2.

DOI:10.1111/ced.14539
PMID:33336376
Abstract

BACKGROUND

Cutaneous ulcers of Behçet disease (BD) are rare but have high morbidity and resistance to conventional therapies. An important and essential aspect of ulcer management is debridement. Regarding maggot therapy (MT), excretions of the green bottle fly, Lucilia sericata, have been shown to have the ability to remove necrotic debris and promote healing.

AIM

To evaluate the efficacy of MT for cutaneous ulcers of BD.

METHODS

In this open-label trial, patients with BD with refractory leg ulcers suitable for MT were enrolled. Maggot application was performed until complete debridement was achieved, and all patients were followed up for 12 months afterwards to assess the total healing of ulcers.

RESULTS

In total, 24 patients with 32 ulcers were enrolled. Using MT, 91.6% of all ulcers were completely debrided. Mean time to debridement was 14.9 days and mean number of cycles required was 5.3. Mean ulcer size was decreased by 23% with treatment. Time to debridement was positively correlated with pretreatment ulcer size and ulcer duration (P = 0.01 and P < 0.01) but not with ulcer depth, comorbidities, smoking, age or sex (P > 0.05 for all). During follow-up, 79.1% of all ulcers healed completely. Mean time required for total healing was positively correlated with ulcer duration, pretreatment and post-treatment ulcer area, ulcer depth and mean time to total debridement (P < 0.03, P = 0.00, P = 0.04 and P < 0.01, respectively).

CONCLUSIONS

To our knowledge, the findings presented in this first and unique study may provide key answers about factors affecting success rate of MT in BD cutaneous ulcers.

摘要

背景

贝赫切特病(BD)的皮肤溃疡罕见,但发病率高,且对常规治疗有耐药性。溃疡处理的一个重要且必不可少的方面是清创。关于蝇蛆疗法(MT),绿头苍蝇(Lucilia sericata)的分泌物已被证明具有清除坏死碎片和促进愈合的能力。

目的

评估 MT 治疗 BD 皮肤溃疡的疗效。

方法

在这项开放标签试验中,招募了适合 MT 的难治性腿部溃疡的 BD 患者。进行蛆虫应用,直到完全清创,所有患者在 12 个月后进行随访,以评估溃疡的总愈合情况。

结果

共纳入 24 例 32 个溃疡患者。使用 MT,所有溃疡的 91.6%完全清创。清创的平均时间为 14.9 天,平均需要 5.3 个周期。治疗后平均溃疡面积减少 23%。清创时间与治疗前溃疡大小和溃疡持续时间呈正相关(P=0.01 和 P<0.01),但与溃疡深度、合并症、吸烟、年龄或性别无关(P>0.05)。在随访期间,所有溃疡中有 79.1%完全愈合。完全愈合所需的平均时间与溃疡持续时间、治疗前和治疗后溃疡面积、溃疡深度以及总清创时间呈正相关(P<0.03,P=0.00,P=0.04 和 P<0.01)。

结论

据我们所知,本项首次且独特的研究中的发现可能为影响 MT 在 BD 皮肤溃疡中成功率的因素提供关键答案。

相似文献

1
Efficacy of maggot debridement therapy on refractory leg ulcers of Behçet disease: an open-label study.蛆虫清创疗法治疗 Behçet 病难治性下肢溃疡的疗效:一项开放标签研究。
Clin Exp Dermatol. 2021 Jul;46(5):834-841. doi: 10.1111/ced.14539. Epub 2021 May 2.
2
The Effect of Bacterial Colonization and Maggot Debridement Treatment on Wound Healing in Chronic Venous Leg Ulcers.细菌定植和蛆虫清创治疗对慢性下肢静脉溃疡伤口愈合的影响。
Clin Lab. 2021 May 1;67(5). doi: 10.7754/Clin.Lab.2020.201137.
3
Maggot therapy for treating diabetic foot ulcers unresponsive to conventional therapy.蛆虫疗法治疗对传统疗法无反应的糖尿病足溃疡。
Diabetes Care. 2003 Feb;26(2):446-51. doi: 10.2337/diacare.26.2.446.
4
Maggot debridement therapy of infected ulcers: patient and wound factors influencing outcome - a study on 101 patients with 117 wounds.感染性溃疡的蛆虫清创疗法:影响治疗结果的患者及伤口因素——对101例患者的117处伤口的研究
Ann R Coll Surg Engl. 2007 Sep;89(6):596-602. doi: 10.1308/003588407X205404.
5
VenUS II: a randomised controlled trial of larval therapy in the management of leg ulcers.VenUS II:幼虫治疗法治疗腿部溃疡的随机对照试验。
Health Technol Assess. 2009 Nov;13(55):1-182, iii-iv. doi: 10.3310/hta13550.
6
Maggot therapy for the treatment of intractable wounds.蛆虫疗法治疗顽固性伤口。
Int J Dermatol. 1999 Aug;38(8):623-7. doi: 10.1046/j.1365-4362.1999.00770.x.
7
Efficacy of Maggot Debridement Therapy on Refractory Atypical Diabetic Foot Ulcers: An Open-Label Study.蛆虫清创疗法治疗难治性非典型糖尿病足溃疡的疗效:一项开放标签研究。
Int J Low Extrem Wounds. 2021 Dec;20(4):315-320. doi: 10.1177/1534734620920403. Epub 2020 May 5.
8
Reappraisal and updated review of maggot debridement therapy in chronic lower extremity ulcers.蛆虫清创疗法在慢性下肢溃疡中的再评估和更新综述。
Int J Dermatol. 2023 Jul;62(7):962-968. doi: 10.1111/ijd.16619. Epub 2023 Mar 7.
9
Impact on wound healing and efficacy of various leg ulcer debridement techniques.各种下肢溃疡清创技术对伤口愈合和疗效的影响。
J Dtsch Dermatol Ges. 2012 Sep;10(9):624-32. doi: 10.1111/j.1610-0387.2012.07952.x. Epub 2012 May 16.
10
Towards next generation maggot debridement therapy: transgenic Lucilia sericata larvae that produce and secrete a human growth factor.迈向新一代蛆虫清创疗法:产生并分泌人类生长因子的转基因丝光绿蝇幼虫
BMC Biotechnol. 2016 Mar 22;16:30. doi: 10.1186/s12896-016-0263-z.

引用本文的文献

1
Expanding access to maggot containment dressings through redesign and innovation.通过重新设计和创新扩大蛆虫隔离敷料的可及性。
Int Wound J. 2025 Jan;22(1):e70100. doi: 10.1111/iwj.70100.